Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(6 sites)
United States
Hoag Memorial Hospital Presbyterian, Newport Beach, California Karmanos Cancer Institute, Detroit, Michigan Northwell Health Zuckerberg Cancer Center, Lake Success, New York University of Texas Southwestern Medical Center, Dallas, Texas The University of Texas MD Anderson Cancer Center, Houston, Texas Virginia Mason Medical Center, Seattle, Washington